Can Inhalable Sensors Transform Early Lung Cancer Diagnosis?

MIT has developed groundbreaking technology that simplifies medlinklung cancer/medlink diagnosis. By inhaling nanoparticle sensors and undergoing a subsequent urine test, detection of tumor presence becomes effortless. These nanosensors, administered via inhaler or nebulizer, interact with cancer-related proteins in the lungs. Upon encountering these proteins, they generate a signal that concentrates in urine, detectable through a straightforward paper test strip. This approach could ...